Yao Xu

1.1k total citations
60 papers, 715 citations indexed

About

Yao Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yao Xu has authored 60 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yao Xu's work include Cancer Diagnosis and Treatment (10 papers), Sarcoma Diagnosis and Treatment (10 papers) and Bone health and treatments (9 papers). Yao Xu is often cited by papers focused on Cancer Diagnosis and Treatment (10 papers), Sarcoma Diagnosis and Treatment (10 papers) and Bone health and treatments (9 papers). Yao Xu collaborates with scholars based in China, Russia and South Africa. Yao Xu's co-authors include Xin Wang, Chao Zhang, Guo‐Qing Zhu, Karl Peltzer, Xing-Ya Gao, Guowen Wang, Владимир П. Баклаушев, Xu Guo, В. П. Чехонин and Guijun Xu and has published in prestigious journals such as Nano Letters, PLoS ONE and Scientific Reports.

In The Last Decade

Yao Xu

53 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yao Xu China 16 242 210 166 154 148 60 715
Alby Elias United States 19 350 1.4× 522 2.5× 88 0.5× 116 0.8× 213 1.4× 38 1.2k
Ivan Presta Italy 19 90 0.4× 125 0.6× 97 0.6× 86 0.6× 318 2.1× 43 913
Tetsuya Kawabe Japan 16 115 0.5× 148 0.7× 222 1.3× 124 0.8× 122 0.8× 39 752
Masato Narita Japan 22 145 0.6× 329 1.6× 89 0.5× 360 2.3× 334 2.3× 74 1.4k
Meng Cheong Wong Singapore 16 109 0.5× 66 0.3× 96 0.6× 71 0.5× 212 1.4× 28 822
Yanna Lei China 16 78 0.3× 241 1.1× 89 0.5× 112 0.7× 263 1.8× 36 771
David M. Poitz Germany 23 102 0.4× 135 0.6× 197 1.2× 127 0.8× 528 3.6× 76 1.2k
Le Zhang China 18 170 0.7× 225 1.1× 48 0.3× 200 1.3× 390 2.6× 53 1.0k
Maximilian J. Schloss Germany 12 68 0.3× 106 0.5× 465 2.8× 142 0.9× 469 3.2× 14 1.4k
Ayşegül İlhan Austria 15 89 0.4× 170 0.8× 52 0.3× 104 0.7× 269 1.8× 29 620

Countries citing papers authored by Yao Xu

Since Specialization
Citations

This map shows the geographic impact of Yao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao Xu more than expected).

Fields of papers citing papers by Yao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao Xu. The network helps show where Yao Xu may publish in the future.

Co-authorship network of co-authors of Yao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yao Xu. A scholar is included among the top collaborators of Yao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao Xu. Yao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ruichao, Zhiwei Chen, Xi Zhang, et al.. (2025). Upconversion luminescence nanosensor based on the inner filter effect for rapid detection of the anticancer drug 6-mercaptopurine. Microchimica Acta. 192(7). 409–409. 1 indexed citations
2.
Cao, Chunyan, Feng Xu, Wenqi Lv, et al.. (2025). Bi-allelic loss-of function variants in ATP2A1 cause autosomal recessive Brody disease. QJM. 118(10). 786–788.
3.
Chen, Long, Jianchao Liu, Xiuxin Han, et al.. (2025). Integrated single-cell and bulk transcriptome analysis of R-loop score-based signature with regard to immune microenvironment, lipid metabolism and prognosis in HCC. Frontiers in Immunology. 15. 1487372–1487372. 2 indexed citations
5.
6.
Xu, Yao, et al.. (2022). Chinese transnational corporations in the Ukraine crisis: risk perception and mitigation. Transnational Corporation Review. 14(4). 371–381. 9 indexed citations
7.
Li, Guanghao, Yongheng Liu, Yanting Zhang, et al.. (2022). A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma. Frontiers in Immunology. 13. 929089–929089. 13 indexed citations
8.
Xu, Yao, Basel Abdelazeem, Kirellos Said Abbas, et al.. (2022). Non-cancer Causes of Death Following Initial Synchronous Bone Metastasis in Cancer Patients. Frontiers in Medicine. 9. 899544–899544. 3 indexed citations
9.
Xu, Yao, Zhiwei Zhong, Yiwen Gao, et al.. (2021). The Mangrove-Derived Diterpenoid Diaporthe B Inhibits the Stemness and Increases the Efficacy of Docetaxel in Prostate Cancer PC-3 Cells. Natural Product Communications. 16(12).
10.
Xu, Yao, Guijun Xu, Min Mao, et al.. (2020). Is there a role for chemotherapy and radiation in the treatment of patients with low-grade myofibroblastic sarcoma?. Clinical & Translational Oncology. 23(2). 344–352. 18 indexed citations
11.
Wang, Yutong, Ziqian Zeng, Mingshuang Tang, et al.. (2020). Sex Disparities in the Clinical Characteristics, Synchronous Distant Metastasis Occurrence and Prognosis: A Pan-cancer Analysis. Journal of Cancer. 12(2). 498–507. 8 indexed citations
12.
Ma, Wenjuan, Xin Wang, Guijun Xu, et al.. (2020). Distant metastasis prediction via a multi-feature fusion model in breast cancer. Aging. 12(18). 18151–18162. 19 indexed citations
13.
Li, Xiantao, Yi‐Min Sun, Zheng Li, et al.. (2019). A novel homozygous mutation in TREM2 found in a Chinese early-onset dementia family with mild bone involvement. Neurobiology of Aging. 86. 201.e1–201.e7. 7 indexed citations
14.
Xu, Yao, et al.. (2019). The clinical feature of bone metastases in lung cancer patients with different pathological types. Zhonghua guke zazhi. 39(6). 329–335. 1 indexed citations
15.
Zhang, Chao, Xu Guo, Yao Xu, et al.. (2019). Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study. Sao Paulo Medical Journal. 137(5). 423–429. 32 indexed citations
16.
Guo, Xu, Yao Xu, Xin Wang, et al.. (2019). Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation. Medical Science Monitor. 25. 1105–1112. 21 indexed citations
18.
Guo, Qi, Chao Zhang, Xu Guo, et al.. (2018). Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study. Cancer Management and Research. Volume 10. 2935–2944. 26 indexed citations
19.
Guo, Xu, Chao Zhang, Qi Guo, et al.. (2018). The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer. Cancer Management and Research. Volume 10. 1639–1646. 38 indexed citations
20.
Gao, Xing-Ya, et al.. (2007). Depressor effect of closed-loop chip system in spontaneously hypertensive rats. Autonomic Neuroscience. 137(1-2). 84–91. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026